Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesReduced TNF-alpha and increased IGF-I levels in the serum of Alzheimer's disease patients treated with the neurotrophic agent Cerebrolysin
International Journal of Neuropsychopharmacology, 07/17/09
Alvarez XA et al. – The results showing for the first time the opposite influence of one anti–dementia treatment on serum TNF–alpha and IGF–I suggest the contribution of both factors to the clinical effects of Cere, and probably other drugs.
Related Articles
Does Diabetes Speed Up Memory Loss In Alzheimers Disease?
ScienceDaily, 10/28/09
Relevance Score: 70%
High Blood Pressure Likely in Alzheimers Offspring
MedLinePlus, 11/04/09
Relevance Score: 69%
New neuroimaging analysis technique identifies impact of Alzheimer's disease gene in healthy brains
EurekAlert, 11/18/09
Relevance Score: 68%
Protective Role For Copper In Alzheimers Disease
ScienceDaily, 10/14/09
Relevance Score: 68%
More Iowans fight Alzheimer's
Internet Source, 11/17/09
Relevance Score: 67%
Today in Dementia...keeping you current
Receive free subspecialty "5-minute updates" via email
25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services
Neurology, 11/30/09
Chronic Stress Is Associated with High Cortisol Levels and Emotional Coping Mechanisms in Amnestic Mild Cognitive Impairment
Dementia and Geriatric Cognitive Disorders, 11/30/09
25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men
Neurology, 11/30/09
Today in Demyelinating Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Erythropoietin in amyotrophic lateral sclerosis: A pilot, randomized, double-blind, placebo-controlled study of safety and tolerability
Amyotrophic Lateral Sclerosis, 11/30/09
Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: A phase II open label clinical trial
Amyotrophic Lateral Sclerosis, 11/30/09
Multiple Sclerosis, Lymphoma and Nasopharyngeal Carcinoma: The Central Role of Epstein-Barr Virus?
European Neurology, 11/30/09
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Erythropoietin in amyotrophic lateral sclerosis: A pilot, randomized, double-blind, placebo-controlled study of safety and tolerability
Amyotrophic Lateral Sclerosis, 11/30/09
Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: A phase II open label clinical trial
Amyotrophic Lateral Sclerosis, 11/30/09
The effect of l-Dopa administration on pursuit ocular movements in suspected Parkinsons disease
Neurological Sciences, 11/30/09
Sponsor
Article Search
Sponsor